These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23840511)

  • 1. Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.
    Corchado S; Márquez M; Montes de Oca M; Romero-Cores P; Fernández-Gutiérrez C; Girón-González JA
    PLoS One; 2013; 8(6):e66619. PubMed ID: 23840511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients.
    Corchado S; López-Cortés LF; Rivero-Juárez A; Torres-Cornejo A; Rivero A; Márquez-Coello M; Girón-González JA
    PLoS One; 2014; 9(7):e101760. PubMed ID: 25013899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
    Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
    J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
    Núñez-Torres R; Macías J; Mancebo M; Frías M; Dolci G; Téllez F; Merino D; Merchante N; Gómez-Mateos J; Guaraldi G; Rivero-Juárez A; Pineda JA; Real LM;
    PLoS One; 2016; 11(12):e0168265. PubMed ID: 27973562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Key Elements in the Innate Immunity System Among Patients with HIV, HCV, and Coinfections of HIV/HCV.
    Moradi M; Tabibzadeh A; Javanmard D; Ghorbani S; Bokharaei-Salim F; Keivani H; Khazeni M; Monavari SHR
    Curr HIV Res; 2020; 18(3):194-200. PubMed ID: 32209045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.
    Yee LJ; Tang J; Herrera J; Kaslow RA; van Leeuwen DJ
    Genes Immun; 2000 Aug; 1(6):386-90. PubMed ID: 11196686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients.
    Talaat RM; Esmail AA; Elwakil R; Gurgis AA; Nasr MI
    Chin J Cancer; 2012 Jan; 31(1):29-35. PubMed ID: 22200181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients.
    Tharwat E; Gad GFM; Nazmy MH; Mohamed HI; Hamza N; Wahid A; Ibrahim ARN
    Immunol Invest; 2019 Apr; 48(3):255-267. PubMed ID: 30204505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.
    Jiménez-Sousa MA; Berenguer J; Rallón N; Pineda-Tenor D; Aldamiz-Echevarria T; Soriano V; García-Álvarez M; Vazquez-Morón S; Restrepo C; Carrero A; Benito JM; Resino S
    Liver Int; 2016 Sep; 36(9):1258-66. PubMed ID: 26836972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-α polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients.
    Tarragô AM; da Costa AG; Pimentel JP; Gomes ST; Freitas FB; Lalwani P; de Araújo AR; Victória Fda S; Victória MB; Vallinoto AC; Sadahiro A; Teixeira-Carvalho A; Martins-Filho OA; Malheiro A
    Hum Immunol; 2014 Nov; 75(11):1075-83. PubMed ID: 25193024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.
    Rallón NI; Soriano V; Naggie S; Restrepo C; Goldstein D; Vispo E; McHutchison J; Benito JM
    AIDS; 2011 May; 25(8):1025-33. PubMed ID: 21505315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
    Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
    Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study.
    Guzmán-Fulgencio M; Berenguer J; Jiménez-Sousa MA; Pineda-Tenor D; Aldámiz-Echevarria T; García-Broncano P; Carrero A; García-Álvarez M; Tejerina F; Diez C; Vazquez-Morón S; Resino S
    J Transl Med; 2015 Jun; 13():206. PubMed ID: 26123260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
    Jabłonowska E; Piekarska A; Koślińska-Berkan E; Omulecka A; Szymańska B; Wójcik K
    Acta Biochim Pol; 2012; 59(3):333-7. PubMed ID: 22924160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection.
    Márquez M; Romero-Cores P; Montes-Oca M; Martín-Aspas A; Soto-Cárdenas MJ; Guerrero F; Fernández-Gutiérrez C; Girón-González JA
    PLoS One; 2015; 10(3):e0119568. PubMed ID: 25775475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
    Mandorfer M; Payer BA; Schwabl P; Steiner S; Ferlitsch A; Aichelburg MC; Stättermayer AF; Ferenci P; Obermayer-Pietsch B; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2015 Mar; 35(3):876-85. PubMed ID: 24905495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy.
    Sitia G; De Bona A; Bagaglio S; Galli L; Paties CT; Uberti-Foppa C; Guidotti LG; Lazzarin A; Morsica G
    Antivir Ther; 2006; 11(3):385-9. PubMed ID: 16759056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.